secwatch.observer — SEC 8-K summary
======================================

Issuer:     ALLURION TECHNOLOGIES, INC. (ALUR)
CIK:        0001964979
Form:       8-K
Filed at:   2023-11-13T23:59:59+00:00
Accession:  0000950170-23-062465
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Allurion Q3 revenue $18.2M (+13% YoY), loss $26.2M; completes AUDACITY trial enrollment
--------------------------------------------------------------------------------

- Revenue $18.2M, up 13% YoY and 40% sequentially from Q2 2023; gross profit 77%.
- Loss from operations $26.2M, including $10M in business combination and stock-based comp expenses.
- Cash balance $79.9M after NYSE listing in August 2023, raising $92M net proceeds.
- Completed enrollment in AUDACITY FDA pivotal trial for Allurion Balloon; PMA submission planned.
- Launched Coach Iris, a generative AI-powered 24/7 weight loss coach.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1964979/000095017023062465/0000950170-23-062465-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1964979/000095017023062465/alur-20231113.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-062465

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer